WO2016022614A1 - Procédé permettant d'évaluer la santé et les prédispositions génétiques d'animaux - Google Patents
Procédé permettant d'évaluer la santé et les prédispositions génétiques d'animaux Download PDFInfo
- Publication number
- WO2016022614A1 WO2016022614A1 PCT/US2015/043693 US2015043693W WO2016022614A1 WO 2016022614 A1 WO2016022614 A1 WO 2016022614A1 US 2015043693 W US2015043693 W US 2015043693W WO 2016022614 A1 WO2016022614 A1 WO 2016022614A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- animal
- animals
- species
- evaluating
- information
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 74
- 238000000034 method Methods 0.000 title claims abstract description 24
- 230000036541 health Effects 0.000 title claims description 17
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 title description 2
- 238000009395 breeding Methods 0.000 claims abstract description 22
- 230000001488 breeding effect Effects 0.000 claims abstract description 22
- 241000283086 Equidae Species 0.000 claims description 25
- 230000002068 genetic effect Effects 0.000 claims description 14
- 241000282472 Canis lupus familiaris Species 0.000 claims description 11
- 241000283690 Bos taurus Species 0.000 claims description 6
- 238000003556 assay Methods 0.000 claims description 6
- 241000283707 Capra Species 0.000 claims description 4
- 241001494479 Pecora Species 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 4
- 241000282832 Camelidae Species 0.000 claims description 3
- 241000282326 Felis catus Species 0.000 claims description 3
- 241000282887 Suidae Species 0.000 claims description 3
- 235000019993 champagne Nutrition 0.000 claims description 3
- 230000002596 correlated effect Effects 0.000 claims description 3
- 229910052709 silver Inorganic materials 0.000 claims description 3
- 239000004332 silver Substances 0.000 claims description 3
- 102100022204 DNA-dependent protein kinase catalytic subunit Human genes 0.000 claims description 2
- 102100034472 H(+)/Cl(-) exchange transporter 4 Human genes 0.000 claims description 2
- 101000619536 Homo sapiens DNA-dependent protein kinase catalytic subunit Proteins 0.000 claims description 2
- 101000710229 Homo sapiens H(+)/Cl(-) exchange transporter 4 Proteins 0.000 claims description 2
- 238000002405 diagnostic procedure Methods 0.000 claims description 2
- 241000894007 species Species 0.000 claims 10
- 102100028734 1,4-alpha-glucan-branching enzyme Human genes 0.000 claims 1
- 102100029815 D(4) dopamine receptor Human genes 0.000 claims 1
- 102100030072 Doublesex- and mab-3-related transcription factor 3 Human genes 0.000 claims 1
- -1 GYSl Proteins 0.000 claims 1
- 102100039939 Growth/differentiation factor 8 Human genes 0.000 claims 1
- 108050006583 Growth/differentiation factor 8 Proteins 0.000 claims 1
- 101001058479 Homo sapiens 1,4-alpha-glucan-branching enzyme Proteins 0.000 claims 1
- 101000865206 Homo sapiens D(4) dopamine receptor Proteins 0.000 claims 1
- 101000864825 Homo sapiens Doublesex- and mab-3-related transcription factor 3 Proteins 0.000 claims 1
- 101000878213 Homo sapiens Inactive peptidyl-prolyl cis-trans isomerase FKBP6 Proteins 0.000 claims 1
- 101001023271 Homo sapiens Laminin subunit gamma-2 Proteins 0.000 claims 1
- 101000611202 Homo sapiens Peptidyl-prolyl cis-trans isomerase B Proteins 0.000 claims 1
- 101000891031 Homo sapiens Peptidyl-prolyl cis-trans isomerase FKBP10 Proteins 0.000 claims 1
- 101000693993 Homo sapiens Sodium channel protein type 4 subunit alpha Proteins 0.000 claims 1
- 102100036984 Inactive peptidyl-prolyl cis-trans isomerase FKBP6 Human genes 0.000 claims 1
- 102100035159 Laminin subunit gamma-2 Human genes 0.000 claims 1
- 102100040283 Peptidyl-prolyl cis-trans isomerase B Human genes 0.000 claims 1
- 108091006268 SLC5A3 Proteins 0.000 claims 1
- 102100027195 Sodium channel protein type 4 subunit alpha Human genes 0.000 claims 1
- 102100020884 Sodium/myo-inositol cotransporter Human genes 0.000 claims 1
- 238000010171 animal model Methods 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 238000012360 testing method Methods 0.000 abstract description 12
- 238000012252 genetic analysis Methods 0.000 abstract description 2
- 241000283073 Equus caballus Species 0.000 description 42
- 230000003542 behavioural effect Effects 0.000 description 15
- 108090000623 proteins and genes Proteins 0.000 description 13
- 108700028369 Alleles Proteins 0.000 description 12
- 208000007623 Lordosis Diseases 0.000 description 12
- 201000010099 disease Diseases 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 230000009191 jumping Effects 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 5
- 238000012549 training Methods 0.000 description 5
- 102000004889 Interleukin-6 Human genes 0.000 description 4
- 108090001005 Interleukin-6 Proteins 0.000 description 4
- 206010061533 Myotonia Diseases 0.000 description 4
- 108010071690 Prealbumin Proteins 0.000 description 4
- 102000009190 Transthyretin Human genes 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000005021 gait Effects 0.000 description 4
- 231100000518 lethal Toxicity 0.000 description 4
- 230000001665 lethal effect Effects 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 108010056852 Myostatin Proteins 0.000 description 3
- 238000004820 blood count Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 210000000003 hoof Anatomy 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 208000005123 swayback Diseases 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 102000006822 Agouti Signaling Protein Human genes 0.000 description 2
- 108010072151 Agouti Signaling Protein Proteins 0.000 description 2
- 241000484025 Cuniculus Species 0.000 description 2
- 206010014989 Epidermolysis bullosa Diseases 0.000 description 2
- 206010020844 Hyperthermia malignant Diseases 0.000 description 2
- 208000018717 Malignant hyperthermia of anesthesia Diseases 0.000 description 2
- 208000021642 Muscular disease Diseases 0.000 description 2
- 201000009623 Myopathy Diseases 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 241000710886 West Nile virus Species 0.000 description 2
- 239000003098 androgen Substances 0.000 description 2
- 230000003466 anti-cipated effect Effects 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 102000054766 genetic haplotypes Human genes 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229940100601 interleukin-6 Drugs 0.000 description 2
- 235000020282 macchiato Nutrition 0.000 description 2
- 201000007004 malignant hyperthermia Diseases 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 235000003715 nutritional status Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 241000651994 Curio Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102100039262 Glycogen [starch] synthase, muscle Human genes 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 101001036130 Homo sapiens Glycogen [starch] synthase, muscle Proteins 0.000 description 1
- 208000007599 Hyperkalemic periodic paralysis Diseases 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 102000004472 Myostatin Human genes 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 241001061106 Sargocentron rubrum Species 0.000 description 1
- 241000422848 Taxodium mucronatum Species 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003230 arteritis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- ZEKANFGSDXODPD-UHFFFAOYSA-N glyphosate-isopropylammonium Chemical compound CC(C)N.OC(=O)CNCP(O)(O)=O ZEKANFGSDXODPD-UHFFFAOYSA-N 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 208000030175 lameness Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000013332 literature search Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 231100001160 nonlethal Toxicity 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 210000005132 reproductive cell Anatomy 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 208000002491 severe combined immunodeficiency Diseases 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000009192 sprinting Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 108091035539 telomere Proteins 0.000 description 1
- 102000055501 telomere Human genes 0.000 description 1
- 210000003411 telomere Anatomy 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K29/00—Other apparatus for animal husbandry
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/02—Animal zootechnically ameliorated
Definitions
- the purchaser could rely on his own experience and those physical traits that could be easily observed. For instance, age can be estimated by an inspection of the teeth by an experienced veterinarian, prior to the purchase of a horse.
- hooves and joint condition can be checked visually, the coat can be checked for overall condition and any parasites, and other traits can be evaluated physically, visually and behaviorally.
- horses and dogs fall into this category. Horses are trained in dressage, jumping, racing, reining, pulling carts and carriages, trial, cutting, ranch, vaulting, endurance and so on. Dogs are trained and evaluated for field events, police work, military work, search and rescue, farm work, and even as guide dogs for the deaf, blind, and mentally disabled. For example, greyhounds are utilized in track racing.
- the present invention is several methods which are based upon the gathering of information from various sources and using that information to: a. assess the existing skills of the animal, b. the likelihood of that animal developing a serious or deadly disease or pathology, c. assessing the likelihood that the animal will respond to training directed towards developing a desired skill and d.
- another method of the present invention is to determine the optimum breeding pair from one or more stallions (males) and one or more mares (females) based upon a predetermined set of selection criteria. Such criteria might be size, color, dressage skills, rodeo skills, jumping height, ability as a draught horse, thoroughbred racing and other valuable or desired traits.
- Fig. 1 is an example of a judge's score card from an equestrian event
- Fig. 2 is a sample of one page from one embodiment of a an owner's survey; and Fig. 3 discloses depictions of a normal horse and two horses suffering from Lordosis.
- the present invention includes the following methods of generating information pertaining to various animals which can include show horses, quarter horses, and thoroughbreds. Though the following discussion is directed toward horses, the present invention can also be used with other valuable animals including but not limited to cattle (colloquially cows), sheep, dogs, camels, cats, pigs, and goats .
- the methods enable the gathering of information which can be used in
- Each of these methods is based upon a compilation of one or more of the following five categories of scores which are obtained from 1) DNA/genetics analysis, 2) a compilation of show scores, 3) Conformation 4) Owner/trainer provided information about the horse and 5)
- genes that indicate health and disease conditions or disease predispositions can include but are not limited to:
- genes for performance and abilities include, but are not limited to:
- FIG. 1 An example a judge's score card for horses (Fig. 1) and behavioral survey of an owners horse (Fig. 2) show the type of subjective and behavioral information that will be gathered and then correlated with the DNA data gathered as described below. As much behavioral information as possible is collected for each horse that will be tested. Typically 100-10,000 horses will be tested for each trait or condition of interest.
- DNA samples will be collected and analyzed from the same horses from which behavioral data (show scores and owner/trainer feedback) has been gathered.
- the DNA samples can be collected from several types of tissues including, but not limited to hair, blood, saliva, buccal swabs, reproductive cells, skin samples and nail/hoof clippings.
- the samples will be extracted and tested for various genetic markers by various analytical techniques that are known to one skilled in the art. Some behavioral traits have already been associated with certain genome sequences but those associations are not definitive.
- the analytical protocol of the present invention would include standard sequencing across the whole the length of one or more gene sequences or regions that are suspected or anticipated to be associated with a behavioral trait.
- the existence of single nucleotide polymorphisms, duplications, deletions and mutations in those sequences would be isolated and identified.
- DNA from a particular animal can be used to identify the genetic markers present in that animal and thus allows for the evaluation of the predisposition of that animal to exhibit those behaviors and posses those capabilities associated with those genetic markers.
- Such traits can include, but are not limited to high and low jumping skills, style, speed, endurance for short, medium or long distances, skill in multiple jumps, temperament, height at maturity, gait style, ability to perform in a given discipline, work ethics, neurosis, strengths, disease predisposition or resistance, and other traits.
- This information will be very valuable in terms of horse value determination, assigning stud fees, discipline suitability, and selecting breeding pairs or cross-matches (in the event there are multiple stallions or mares to one horse as a potential match).
- the proper training regimen can be selected in order to maximize the horse's development while minimizing stress and illness.
- Conformation deals with the physical attributes of the horse and evaluates the horse's bone structure, musculature and body proportions in relation to each other and the intended use of the horse.
- a horse that is to be used a draught animal would need to have a different confirmation that one that will be used as a jumper or a cutting horse.
- Conformational traits may be measured in angles for shoulder, hip and neck set, as well as back length, leg length, pastern length and angle, height and weight, head and ear shape, musculature, hoof shape and hardness, shoulder versus hip height, and other characteristics.
- Questionnaires have been generated which gather information from owners about specific behavior and skills for their horses. Questionnaires are directed to a number of traits which include, but are not limited to, spooking, jumping skill, speed, dressage, temperament and gaits or gait quality/ability.
- questionnaires relating to the health of the horse are also gathered.
- Such questionnaires could include, but are not limited to information about the respiratory system, digestive system, lameness, and bacterial, fungal or viral susceptibility. See Fig. 2 for on page from an example of an owner's questionnaire.
- CBC Complete Blood Count which includes white blood cell count, red blood cell count, hemoglobin level, hematocrit, platelet count and other blood cell morphology evaluations and measurements.
- IL-6 interleukin 6
- organ function e.g., kidney, liver and muscle
- IL-6 assays can identify chronic inflammatory conditions in older horses. Increased IL-6 values in humans correlate with greater/earlier mortality and cardiovascular complications.
- DNA related tests such as the assay of telomere length provides additional insights into the present and future health of the animal which may include biological age, underlying health or disease, as well as prior health and possible lifespan.
- Imaging techniques such as X-rays, computerized tomography (CT) scans and magnetic resonance imaging (MRI) can be used to gather sophisticated data about the condition and health of the horse.
- CT computerized tomography
- MRI magnetic resonance imaging
- Fibrinogen - This test is currently utilized in the detection of acute inflammation and may provide a measure of exercise status (too much, too little). Owners and trainers can then adjust the horses' exercise regimen specific to the animal tested.
- Fecal Ulcer PCR - This test may provide a non-invasive, early diagnosis for ulcer onset and the results of which can provide the caregiver an appropriate solution, possibly preventing progression and unnecessary medication.
- Transthyretin An assay that provides short-term nutritional status by measuring the concentration of transthyretin in the blood. Transthyretin's concentration more closely reflects recent dietary intake rather than overall nutritional status providing a glimpse into the proper feeding regimen for the animal athlete being monitored.
- Each of the criteria is given a weighted value in terms of calculating the overall Performance Index.
- the value assigned to each of these five categories is based upon the intended use of the animal which dictates the type of Performance Index that will be generated. Furthermore the value assigned is a subjective measurement assigned by the experienced technician and based upon that technician's knowledge, the database information collected on that animal, its current experience, performance, and the type of Performance Index being generated.
- Performance Index Report for a jumping horse.
- the Performance Index is based upon gathering the information needed to evaluate a jumping horse. This would include specific gene assays, lab tests and owner survey questionnaires directed to the traits needed for a good jumping horse.
- the overall Performance Index for this example would be 82/100 which is the arithmetic average of all of the values in the third column.
- Each Performance Index is designed to assess certain and specific traits. In order to achieve that, specific factors in each of the five categories are used. For example, Conformation would be judged differently for horse that would have different uses.
- the Owner Feedback Questionnaires would ask different questions if the horse were to be a dressage horse as opposed to a reining, cutting, racing, or a jumping horse.
- a Performance Index can be repeated at desired intervals in order to measure the health, aging and training effectiveness of an animal.
- the information obtained from the five categories discussed about can be used for other purposes such as Breeding Cross-Match Evaluations. Many times a horse owner is looking to obtain a horse with certain characteristics. It is possible to evaluate a specific mare and stallion to determine what the likelihood of the offspring of that breeding or cross would yield a horse having the specific characteristic that the owner is looking for. It may be color, temperament, size, conformation, speed, height, disease avoidance or soundness as well as any other characteristic that can be measured as described in the five categories given above. It may also be a situation in which the owner already owns a horse and wants to identify a breeding animal that would provide the best chance of the desired offspring.
- the breed matching database would then be searched for horses with those qualifications as potential matches to the planned breeding:
- a mare with Red coat (genetically denoted as “e/e") and Sprint Type myostatin genes (genetically denoted as “C/C”) could be matched with a stallion whose genetic Sprint type was also "C/C", his base coat color as "e/e” however, he would ALSO need to have the Cream modifier (denoted as "Cr”) in order to produce the Palomino color in the foal:
- the function of the Breed Match is to utilize the genetic analysis, performance information, math and science to increase probabilities of the desired offspring while reducing the probabilities of inducing disease and unwanted animals.
- a breed match service will reveal the alleles/sets or alleles in any given region(s) having to do with the desired/undesired trait and provide the safest/best breeding options for any given animal in a simple cross-match chart. For example:
- TEST INFO (YourHorse is a fictitious name used to protect the confidentiality of the owner and horse as given in the actual report provided below.)
- YourHorse is a black or dark bay horse with the capability of passing on the colors Black (E), Red (e), and white markings (DW20 - the coat pattern allele that may add white markings to her coat and appear similar to "Splashed White”) to offspring. While many forms of white can be lethal to foals when inherited from both parents, the DW20 variety is known not to be lethal as either homozygous (two copies of the same gene) or heterozygous (one copy from one parent and none from the other).
- Black/Red +/- Ee Black Factor detected Red Factor detected
- a critical element of the present invention involves the combination of many various clinical tests in a single panel that can be ordered and paid for from a single vendor.
- an owner would need to arrange for tests with a wide range of vendors in order to achieve the comprehensive set of data that the panel of the present invention provides by itself and many of the tests are simply not available on the market today.
- questions and follow-up can be conducted with the single vendor. This facilitates comprehensive discussion and
- the methods of the described invention can be applied to a wide range of other animals including but not limited to cattle, sheep, goats, dogs, camels, cats, pigs, goats as well companion, laboratory and service animals.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Environmental Sciences (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
L'invention concerne des procédés basés sur la collecte d'informations issues de différentes sources et concernant des animaux. Les informations sont basées sur des tests en laboratoire, des analyses génétiques et des observations provenant de propriétaires et/ou d'entraîneurs et concernant différents traits pouvant être facilement observés. Sur la base de cette collection d'informations, un procédé génère un indice de performance qui note ou classe un animal en termes de capacité de l'animal à fonctionner pour le but prévu. D'autres procédés concernent la possibilité de sélectionner une paire reproductrice optimale parmi un ou plusieurs étalons et/ou une ou plusieurs juments susceptibles de produire une descendance présentant les traits souhaités.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462033093P | 2014-08-04 | 2014-08-04 | |
US62/033,093 | 2014-08-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2016022614A1 true WO2016022614A1 (fr) | 2016-02-11 |
WO2016022614A8 WO2016022614A8 (fr) | 2016-03-10 |
Family
ID=55264454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2015/043693 WO2016022614A1 (fr) | 2014-08-04 | 2015-08-05 | Procédé permettant d'évaluer la santé et les prédispositions génétiques d'animaux |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2016022614A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2621382C1 (ru) * | 2016-04-11 | 2017-06-05 | Федеральное государственное бюджетное учреждение высшего образования Южно-Уральский государственный аграрный университет | Способ определения рабочих качеств служебных собак |
CN108684610A (zh) * | 2018-05-31 | 2018-10-23 | 贵州省仁怀市尚德养殖有限公司 | 一种山羊养殖方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107484712B (zh) * | 2017-08-28 | 2020-01-31 | 广西沙田仙人滩农业投资有限公司 | 一种山羊的防病饲养方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040235061A1 (en) * | 2001-05-24 | 2004-11-25 | Wilkie Bruce N. | Methods for selecting and producing animals having a predicted level of immune response, disease resistance or susceptibility, and/or productivity |
WO2008034177A1 (fr) * | 2006-09-18 | 2008-03-27 | The University Of Sydney | Test de performances équines |
US20110262915A1 (en) * | 2008-09-11 | 2011-10-27 | Emmeline Hill | Method for predicting the athletic performance potential of a subject |
US8771943B2 (en) * | 2008-09-11 | 2014-07-08 | University College Dublin—National University of Ireland, Dublin | Method for predicting athletic performance potential |
-
2015
- 2015-08-05 WO PCT/US2015/043693 patent/WO2016022614A1/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040235061A1 (en) * | 2001-05-24 | 2004-11-25 | Wilkie Bruce N. | Methods for selecting and producing animals having a predicted level of immune response, disease resistance or susceptibility, and/or productivity |
WO2008034177A1 (fr) * | 2006-09-18 | 2008-03-27 | The University Of Sydney | Test de performances équines |
US20110262915A1 (en) * | 2008-09-11 | 2011-10-27 | Emmeline Hill | Method for predicting the athletic performance potential of a subject |
US8771943B2 (en) * | 2008-09-11 | 2014-07-08 | University College Dublin—National University of Ireland, Dublin | Method for predicting athletic performance potential |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2621382C1 (ru) * | 2016-04-11 | 2017-06-05 | Федеральное государственное бюджетное учреждение высшего образования Южно-Уральский государственный аграрный университет | Способ определения рабочих качеств служебных собак |
CN108684610A (zh) * | 2018-05-31 | 2018-10-23 | 贵州省仁怀市尚德养殖有限公司 | 一种山羊养殖方法 |
Also Published As
Publication number | Publication date |
---|---|
WO2016022614A8 (fr) | 2016-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Haskell et al. | Genetic selection for temperament traits in dairy and beef cattle | |
Clegg et al. | C-Well: The development of a welfare assessment index for captive bottlenose dolphins (Tursiops truncatus) | |
Battini et al. | Invited review: Animal-based indicators for on-farm welfare assessment for dairy goats | |
Bateson | Independent inquiry into dog breeding | |
Dalla Costa et al. | Equine on-farm welfare assessment: A review of animal-based indicators | |
Tomkins et al. | Associations between motor, sensory and structural lateralisation and guide dog success | |
König v. Borstel | Assessing and influencing personality for improvement of animal welfare: a review of equine studies. | |
Gibbons et al. | Responsiveness of dairy cows to human approach and novel stimuli | |
US20200131589A1 (en) | Method for evaluating health and genetic predisposition of animals | |
Arvelius et al. | Genetic analysis of a temperament test as a tool to select against everyday life fearfulness in Rough Collie | |
Rooney et al. | Pedigree dog breeding in the UK: a major welfare concern? | |
Leighton et al. | A solution for the shortage of detection dogs: a detector dog center of excellence and a cooperative breeding program | |
Abbott | The practice of sheep veterinary medicine | |
Ebinghaus et al. | How to measure dairy cows’ responsiveness towards humans in breeding and welfare assessment? A comparison of selected behavioural measures and existing breeding traits | |
Aubé et al. | Assessment of dairy cow welfare at pasture: measures available, gaps to address, and pathways to development of ad-hoc protocols | |
WO2016022614A1 (fr) | Procédé permettant d'évaluer la santé et les prédispositions génétiques d'animaux | |
Ripollés-Lobo et al. | Evaluation of potential effects and genetic parameters in conformational limb defects in Pura Raza Española horses | |
Taylor et al. | Exercise-induced collapse of Labrador retrievers: survey results and preliminary investigation of heritability | |
Takeda et al. | Genetic relationships between temperament of calves at auction and carcass traits in Japanese Black cattle | |
Peixoto et al. | Environmental and genetic effects on the temperament variability of Guzerá (Bos indicus) females. | |
Mugenda | Refining and validating an on-site canine welfare assessment tool developed for use in commercial breeding kennels | |
Gebhart et al. | The 2011 South Dakota equitarian survey and comparative analysis of equine welfare on a South Dakota Native American reservation | |
Rather | Genetic evaluation of kashmir merino sheep at organized farms | |
Romero et al. | Validation of an Animal Welfare Assessment Protocol for Zebu Beef Farms within Pasture-Based Systems under Tropical Conditions | |
Dwyer et al. | Sheep welfare: a future perspective |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15830022 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 15830022 Country of ref document: EP Kind code of ref document: A1 |